Neuro-oncology

EGFR and EGFRvIII coopt host defense pathways, promoting progression in glioblastoma.

Neuro-oncology

An Z, Fan QW, Wang L, Yoda H, Barata MJ, Jimenez-Morales D, Phillips JJ, Swaney DL, Stevenson E, Lee E, Krogan N, Weiss WA

Clinical Significance and Molecular Annotation of Cellular Morphometric Subtypes in Lower Grade Gliomas discovered by Machine Learning.

Neuro-oncology

Liu XP, Jin X, Ahmadian SS, Yang X, Tian SF, Cai YX, Chawla K, Snijders AM, Xia Y, van Diest PJ, Weiss WA, Mao JH, Li ZQ, Vogel H, Chang H

Betacellulin drives therapy resistance in glioblastoma.

Neuro-oncology

Fan Q, An Z, Wong RA, Luo X, Lu ED, Baldwin A, Mayekar MK, Haderk F, Shokat KM, Bivona TG, Weiss WA

DDIS-33. SELECTIVE AND COMPLETE INHIBITION OF mTORC1 BY BI-STERIC mTOR INHIBITORS DRIVES THERAPEUTIC RESPONSE IN GLIOBLASTOMA.

Neuro-oncology

Qi Wen Fan, Edward Lorenzana, Xujun Luo, Robin Lea, Ozlem Aksoy, Zhenyi An, Tomoko Ozawa, Douglas Wassarman, Kevan Shokat, James Aggen, Jaqueline A M Smith, Mallika Singh, Nicholas Butowski, David Raleigh, William Weiss

THER-08. RAPLINK-1 COOPERATES WITH INHIBITORS OF Bcl-2/Bcl-xl TO INDUCE APOPTOSIS IN GLIOBLASTOMA.

Neuro-oncology

Xujun Luo, Qi-Wen Fan, Kevan M Shokat, William A Weiss

An oncolytic measles virus-sensitive Group 3 medulloblastoma model in immune-competent mice.

Neuro-oncology

Lal S, Carrera D, Phillips JJ, Weiss WA, Raffel C

CSIG-42. UNDERSTANDING THE ROLE OF TRANSLATIONAL CONTROL IN MYCN-DRIVEN MEDULLOBLASTOMA.

Neuro-oncology

Ozlem Aksoy, Qiwen Fan, Kevan Shokat, Davide Ruggero, William Weiss

Pediatric high-grade glioma: biologically and clinically in need of new thinking.

Neuro-oncology

Jones C, Karajannis MA, Jones DTW, Kieran MW, Monje M, Baker SJ, Becher OJ, Cho YJ, Gupta N, Hawkins C, Hargrave D, Haas-Kogan DA, Jabado N, Li XN, Mueller S, Nicolaides T, Packer RJ, Persson AI, Phillips JJ, Simonds EF, Stafford JM, Tang Y, Pfister SM, Weiss WA

Pages